Tracked shipping to New Zealand with premium packaging for just NZ$15 

Ship to
New Zealand
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Select your country

Americas

Europe

Rest of the world

portada Human Retroviral Infections. Immunological and Therapeutic Control
Type
Physical Book
Publisher
Year
2013
Language
English
Pages
392
Format
Paperback
Dimensions
23.4x15.6x2 cm
ISBN13
9781475781670

Human Retroviral Infections. Immunological and Therapeutic Control

Kenneth E. Ugen;Mauro Bendinelli;Herman Friedman (Author) · Springer · Paperback

Human Retroviral Infections. Immunological and Therapeutic Control - Kenneth E. Ugen;Mauro Bendinelli;Herman Friedman

New Book Imported to New Zealand
Delivery: 17 Dec - 04 Jan Shipping: 11 to 15 business days.
NZ$ 136.58
Import costs and 15% GST included in the price ✅
NZ$ 136.58

Synopsis "Human Retroviral Infections. Immunological and Therapeutic Control"

The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leukemia (ATL). Several years later, the acquired immunodeficiency syndrome (AIDS) epidemic began, and it was dem- strated that a retrovirus, originally designated the human T cell lymp- tropic virus type 3, was the causal agent of this syndrome. This virus, later named the human immunodeficiency virus type 1 (HIV-1), has since been extensively studied in terms of its pathogenesis as well as its ability to elicit immune responses. In that time, a tremendous amount of information has been obtained about the virus. Although recent drug regimens have been useful in significantly lowering viral loads and perhaps maintaining an asymptomatic state among individuals infected with HIV-1, an established "cure" for AIDS eludes us. In addition, the effective drug therapies are very expensive, and are not available to infected people in the third world, where greater than 90% of new infections occur. Furthermore, the development of viral resistance against the drug therapies is an additional concern. Despite extensive study, no effective vaccine has been developed. One of the problems in developing an effective vaccine against HIV-1 is the ability of the virus, particularly in the immunogenic envelop glycoprotein, to undergo amino acid hypervariability.

Customers reviews

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews